Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting
US10604501B2 · kind B2 · utility
2Cited by
6References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2017 |
| Grant date | Mar 31, 2020 |
| Priority date | — |
| Expiry date | Jun 13, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of prodrugs susceptible to nitroreductase (NTR) activation. In particular, provided herein are mitochondria-targeting prodrug compounds and probes, including profluore scent near-infrared (NIR) probes and non-fluorescent prodrugs, as well as to methods of using said prodrug compounds and probes for imaging mitochondria and for mitochondria-specific delivery of therapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.